Could HIV drugs beat long COVID? new trial begins
NCT ID NCT06511063
First seen Feb 02, 2026 · Last updated Apr 30, 2026 · Updated 13 times
Summary
This study tests whether two HIV antiviral drugs can reduce symptoms in adults with Long COVID. 90 participants will take either Truvada, Selzentry, or a placebo pill daily for 90 days. The goal is to see if targeting hidden viral activity improves health and quality of life.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LONG COVID are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Cohen Center for Recovery from Complex Chronic Illnesses (CoRE)
RECRUITINGNew York, New York, 10029, United States
Contact
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.